外科医生与医院手术量对髋部骨折术后并发症和死亡率的影响
基于Kaiser Permanente髋部骨折登记系统,前瞻性纳入14,294例60岁及以上手术治疗的髋部骨折患者,按主刀医生和医院过去12个月手术量三分位分组,分析手术量与术后30天、90天、1年死亡率及再手术、内科并发症、非计划再入院的关系。结果显示手术量与各项结局均无显著关联(p > 0.05),数据不支持将髋部骨折患者优先转诊至高手术量医生或医院。证据等级为治疗性IV级。
要点
- 在14,294例60岁及以上手术治疗的髋部骨折患者中,医生和医院手术量与30天、90天、1年死亡率均无显著关联(p > 0.05)。
- 医生和医院手术量与再手术、内科并发症及30天非计划再入院亦无显著关联(p > 0.05)。
- 与全关节置换等其他骨科手术不同,本研究数据不支持将髋部骨折患者优先转诊至高手术量医生或医院。
核心结论
- 在大规模整合医疗系统中,髋部骨折术后死亡率、再手术、内科并发症和非计划再入院率不因主刀医生或医院手术量不同而存在差异。
- 与全关节置换等其他骨科手术不同,本研究数据不支持将髋部骨折患者优先转诊至高手术量医生或医院治疗。
研究设计与样本
- 利用Kaiser Permanente髋部骨折登记系统前瞻性记录管理医疗系统内手术治疗髋部骨折的信息。
- 纳入所有60岁及以上接受手术治疗的髋部骨折患者,共14,294例。
- 主刀医生和医院手术量定义为既往12个月内实施的髋部骨折手术数量,并按三分位分为低、中、高三组。
- 主要结局为术后1年死亡率;次要结局为术后30天和90天死亡率、终身再手术、90天内科并发症及30天非计划再入院。
- 采用多因素logistic回归和Cox比例风险回归分析手术量与结局的关系,并控制潜在混杂变量。
主要发现
- 研究样本中女性占71%,白人占79%,平均年龄81岁。
- 总体死亡率30天为6%,90天为11%,1年为21%。
- 主刀医生或医院手术量与30天、90天、1年死亡率均无关联(p > 0.05)。
- 主刀医生或医院手术量与再手术、内科并发症、非计划再入院也均无关联(p > 0.05)。
关键数值与推荐
- 主刀医生和医院手术量按既往12个月实施的髋部骨折手术数量三分位分为低、中、高三组。
- 主要结局为术后1年死亡率,次要结局包括30天和90天死亡率、终身再手术、90天内科并发症和30天非计划再入院。
- 手术量与各项结局的关联均无统计学意义(p > 0.05)。
临床怎么用
- 本研究数据不支持将髋部骨折患者优先转诊至高手术量主刀医生或医院治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prior studies have examined the relationship between surgeon and hospital volumes and outcome following hip fracture surgical procedures, but the results have been inconclusive. The purpose of this study was to assess the hip fracture volume-outcome relationship by analyzing data from a large, managed care registry. METHODS: The Kaiser Permanente Hip Fracture Registry prospectively records information on surgically treated hip fractures within the managed health-care system. Using this registry, all surgically treated hip fractures in patients 60 years of age or older were identified. Surgeon and hospital volume were defined as the number of hip fracture surgical procedures performed in the preceding 12 months and were divided into tertiles (low, medium, and high). The primary outcome was mortality at 1 year postoperatively. Secondary outcomes were mortality at 30 and 90 days postoperatively as well as reoperation (lifetime), medical complications (90-day), and unplanned readmission (30-day). To determine the relationship between volume and these outcome measures, multivariate logistic and Cox proportional hazards regression were performed, controlling for potentially confounding variables. RESULTS: Of 14,294 patients in the study sample, the majority were female (71%) and white (79%), and the mean age was 81 years. The overall mortality rate was 6% at 30 days, 11% at 90 days, and 21% at 1 year. We did not find an association between surgeon or hospital volume and mortality at 30 days, 90 days, or 1 year (p > 0.05). There was also no association between surgeon or hospital volume and reoperation, medical complications, or unplanned readmission (p > 0.05). CONCLUSIONS: In this analysis of hip fractures treated in a large integrated health-care system, the observed rates of mortality, reoperation, medical complications, and unplanned readmission did not differ by surgeon or hospital volume. In contrast to other orthopaedic procedures, such as total joint arthroplasty, our data do not suggest that hip fractures need to be preferentially directed toward high-volume surgeons or hospitals for treatment. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
引用
- Okike K, Chan PH, Paxton EW, et al. Effect of Surgeon and Hospital Volume on Morbidity and Mortality After Hip Fracture. J Bone Joint Surg Am. 2017. PMID: 28926384. doi:10.2106/JBJS.16.01133
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。